| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 11/06/2008 | WO2008132516A1 Toll-like receptor binding epitope and compositions for binding thereto |
| 11/06/2008 | WO2008132494A1 Truncated variant of the mammalian target for rapamycin (mtor) protein |
| 11/06/2008 | WO2008132485A2 Mutants of interleukin- 1 receptor antagonist and uses thereof |
| 11/06/2008 | WO2008132477A1 Compounds and uses thereof |
| 11/06/2008 | WO2008132435A1 Y-receptor agonists |
| 11/06/2008 | WO2008132264A1 Citrulinated fibrin-filaggrin chimeric polypeptide capable of detecting the antibodies generated in rheumatoid arthritis |
| 11/06/2008 | WO2008132231A1 Plants having improved growth characteristics under reduced nutrient availability and a method for making the same |
| 11/06/2008 | WO2008131927A1 Immediate protection against pathogens via mva |
| 11/06/2008 | WO2008131908A1 S100a9 interaction screening method |
| 11/06/2008 | WO2008115061A3 Dual targeting system |
| 11/06/2008 | WO2008096368A3 A novel process for production of recombinant human g-csf |
| 11/06/2008 | WO2008096354A3 Means and methods of producing fruits with high levels of anthocyanins and flavonols |
| 11/06/2008 | WO2008091911A3 Use of antibody conjugates |
| 11/06/2008 | WO2008091682A3 Soluble fc gamma r1a for reducing inflammation |
| 11/06/2008 | WO2008091306A3 Methods to utilize invertebrate chemosensory proteins for industrial and commercial uses |
| 11/06/2008 | WO2008089152A3 The integrin activation interface |
| 11/06/2008 | WO2008086006A3 Sp35 antibodies and uses thereof |
| 11/06/2008 | WO2008081291A3 Yeast, recombinant pig lactoferrin, expression vector of recombinant pig lactoferring gene, recombinant pig lactoferrin and production processes thereof. |
| 11/06/2008 | WO2008072075A3 Transferrin fusion protein libraries |
| 11/06/2008 | WO2008067305A3 Polypeptides comprising intracytoplasmic death domain and nkg2d ligand domain |
| 11/06/2008 | WO2008063479A3 Pancreatic cancer biomarkers |
| 11/06/2008 | WO2008060811A3 Peptides facilitating or inhibiting anterograde transport |
| 11/06/2008 | WO2008057144A3 Functional negative regulatory domain sequences from human notch1 and 2 and isolated lnr domains from human notch1 |
| 11/06/2008 | WO2008047006A8 Polynucleotides and polypeptides coded by said polynucleotides involved in the biosynthesis of congocidine and derivatives thereof |
| 11/06/2008 | WO2008036337A3 Predicted phosphorylation sites |
| 11/06/2008 | WO2008030429A3 Novel haplotype of human t2r receptor ht2r50 and its use in assays for identifying human bitter taste modulators |
| 11/06/2008 | WO2008027252A9 Poxvirus ifn- ybp c-terminal domain |
| 11/06/2008 | WO2008014382A3 System and method for controlling g-protein coupled receptor pathways |
| 11/06/2008 | WO2007138382A3 Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis |
| 11/06/2008 | WO2007136663A3 Antibiotic/bone morphogenic protein formulation and method of treatment |
| 11/06/2008 | WO2007123675A3 Crystal structure of human gpvi and applications thereof |
| 11/06/2008 | WO2007120673A3 Immunogenic wt-1 peptides and methods of use thereof |
| 11/06/2008 | WO2007106762A3 Alzheimer's disease biomarkers and methods of use |
| 11/06/2008 | WO2007101063A3 Treatment of development-related disorders |
| 11/06/2008 | WO2007100580A3 Antibodies recognizing a highly expressed putative antigen of ca-mrsa and methods of use |
| 11/06/2008 | WO2007089601A3 Nogo receptor antagonists |
| 11/06/2008 | WO2007087420A9 Production of proteins carrying oligomannose or human-like glycans in yeast and methods of use thereof |
| 11/06/2008 | WO2004085625A3 Proteins associated with cell growth, differentiation, and death |
| 11/06/2008 | US20080276336 Methods For Identifying Proteins With Starch Phosphorylating Enzymatic Activity |
| 11/06/2008 | US20080276335 Nucleic acid molecules and other molecules associated with plants |
| 11/06/2008 | US20080276334 Nucleic acid molecules and other molecules associated with plants |
| 11/06/2008 | US20080275220 Securing polypeptide solution against exogenous stress via filling containers so as to prevent formation of gaseous headspace |
| 11/06/2008 | US20080275219 Multimolecular complexes for cell-free synthesis of preferential proteins |
| 11/06/2008 | US20080275218 Ly6h gene |
| 11/06/2008 | US20080275217 Filamin A interacting protein 1 for use in directed destruction of actin binding protein filamin-1; treating neurodegenerative disorders |
| 11/06/2008 | US20080275214 Viral peptides for use in activating immune response to treat and prevent viral infection |
| 11/06/2008 | US20080275139 Cyclodextrin-Containing Polymers and Uses Thereof |
| 11/06/2008 | US20080275017 Aromatic sulfenates for type i phototherapy |
| 11/06/2008 | US20080274990 Cog47 Protein and S100beta Gene Polymorphism |
| 11/06/2008 | US20080274981 Compositions and methods for regulating apoptosis |
| 11/06/2008 | US20080274977 Treating stroke and other diseases without inhibiting N-type calcium channels |
| 11/06/2008 | US20080274974 Process for removing viruses in fibrinogen solutions and fibrinogen obtained by said process |
| 11/06/2008 | US20080274973 Isolated polypeptides comprising sequence 4 fragments; agonists, antagonists, diagnostic reagents |
| 11/06/2008 | US20080274972 T-cell epitope peptides |
| 11/06/2008 | US20080274971 Use of ACRP30 Globular Head to Promote Increases in Muscle Mass and Muscle Differentiation |
| 11/06/2008 | US20080274970 Vascular adhesion molecules and modulation of their function |
| 11/06/2008 | US20080274969 Albumin-Fused Kunitz Domain Peptides |
| 11/06/2008 | US20080274968 In vitro methods for detecting renal cancer |
| 11/06/2008 | US20080274967 Variants of Pigment Epithelium Derived Factor and Uses Thereof |
| 11/06/2008 | US20080274964 Human Spasmolytic Polypeptide in Glycosylated Form |
| 11/06/2008 | US20080274962 Voltage Dependent Anion Channel (Vdac1) Compositions and Methods of Use Thereof for Regulating Apoptosis |
| 11/06/2008 | US20080274961 Respiratory system disorders; lung hypotensive agents; also pituitary adenylate cyclase activated peptide |
| 11/06/2008 | US20080274960 Fibrosis Inhibitor for Implanted Organ |
| 11/06/2008 | US20080274959 Actinomadura Chromoprotein, Apoprotein and Gene Cluster |
| 11/06/2008 | US20080274958 Glycosylation of peptides via o-linked glycosylation sequences |
| 11/06/2008 | US20080274957 Rgd-enriched gelatine-like proteins with enhanced cell binding |
| 11/06/2008 | US20080274956 Fusion Protein Comprising a Bh3-Domain of a Bh3-Only Protein |
| 11/06/2008 | US20080274955 Prevent migration,adhesion, proliferation of endiothelial cells; angiogenesis inhibition; induction apoptosis; anticancer agents; vascular disorders; artheriosclerosis; vision disorders; retinopathy; antiarthritic agents;lupus; skin disorders |
| 11/06/2008 | US20080274954 Novel protein; rho genes rho proteins; guanosine triphosphate binding proteins; antibody against the protein encodes polynucleotide; detection; determinating esophagual cancer |
| 11/06/2008 | US20080274953 Method of Preparing a Protein Aggregate and a Pharmaceutical Preparation |
| 11/06/2008 | US20080274950 Intensify binding between cadherin molecules by reducing intramolecular binding within the cadherin molecules; reduce ionic bonding |
| 11/06/2008 | US20080274948 Conjugates of Hydroxyalkyl Starch and G-Csf |
| 11/06/2008 | US20080274542 Canine and feline 5T4 polypeptide sequences for use in generating vaccine for prevention and treatment of cell proliferative disorders; veterinary medicine |
| 11/06/2008 | US20080274534 Virus Filtration of Liquid Factor VII Compositions |
| 11/06/2008 | US20080274508 Expression system for enhancing solubility and immunogeneicity of recombinant proteins |
| 11/06/2008 | US20080274505 Polynucleotide encoding a novel TRP channel family member, LTRPC3, and splice variants thereof |
| 11/06/2008 | US20080274504 Expression vector comprising nucleotide sequences coding human estrogen receptor for use as negative regulator of heregulin and treatment for prostatic and breast cancers |
| 11/06/2008 | US20080274502 Bacillus Thuringiensis CryET33 and CryET34 Compositions and Uses Therefor |
| 11/06/2008 | US20080274501 Method of purifying acidic proteins expressed in plants |
| 11/06/2008 | US20080274497 Expressing heterologous polypeptide in eukaryotic tissue; tissue engineering; producing vaccines to aid in protection against viral diseases |
| 11/06/2008 | US20080274472 Novel kinases and uses thereof |
| 11/06/2008 | US20080274468 Novel means for the diagnosis and therapy of ctcl |
| 11/06/2008 | US20080274230 Comprising protein, lipid, carbohydrate and ferrous fumarate, ferrous succinate, ferric saccharate, ferric glycerophosphate, ferrous citrate, ferrous tartrate, ferric pyrophosphate, or ferric orthophosphate; does not significantly negate or eliminate inherent antimicrobial activity of human milk |
| 11/06/2008 | US20080274170 Peptide epitopes of apolipoprotein b |
| 11/06/2008 | US20080274155 Chimeric Cannulae Proteins, Nucleic Acids Encoding Them And Methods For Making And Using Them |
| 11/06/2008 | US20080274145 whole cell or acellular vaccines against pathogenic Gram negatives such as Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica |
| 11/06/2008 | US20080274144 Genetically engineered or synthetically produced HCV (hepatitis C virus) E1 envelope proteins or parts thereof comprising disulfides between specific cysteine residues; viral-like particles; biodrugs |
| 11/06/2008 | US20080274142 Hinge (hydrophobic pocket) region mutation attenuation; decreased viscerotropism; vaccines |
| 11/06/2008 | US20080274139 Attenuated microorganisms for the treatment of infection |
| 11/06/2008 | US20080274132 Vaccines for blocking transmission of plasmodium vivax |
| 11/06/2008 | US20080274131 Molecular antigen arrary |
| 11/06/2008 | US20080274130 Rabies Virus Vector Systems and Compositions and Methods Thereof |
| 11/06/2008 | US20080274129 Hla-A2 Tumor Associated Antigen Peptides and Compositions |
| 11/06/2008 | US20080274128 Heat shock protein-based vaccines and immunotherapies |
| 11/06/2008 | US20080274126 Oral Vaccines for Fish |
| 11/06/2008 | US20080274113 Immunoglobulin specific to actin-myosin machinery of malarial parasite; prevention protozoal diseases |
| 11/06/2008 | US20080274112 Axonal growth receptor for use in designing immunoglobulins for prevention and treatment of nervous system, cardiovascular, vision and/or spinal cord injury |
| 11/06/2008 | US20080274111 Pancreatic Cancer Genes |
| 11/06/2008 | US20080274109 Nucleotide sequences coding chemokines for use in dianosis of infection, arteriosclerosis, autoimmune, inflammatory, allergic and arthritic disorders |
| 11/06/2008 | US20080274099 Oncofoetal domain specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders |